5,554 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Axecap Investments LLC

Axecap Investments LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,554 shares of the healthcare conglomerate’s stock, valued at approximately $3,247,000. UnitedHealth Group accounts for about 2.5% of Axecap Investments LLC’s investment portfolio, making the stock its 14th largest holding.

A number of other institutional investors have also made changes to their positions in the stock. Key Client Fiduciary Advisors LLC acquired a new position in shares of UnitedHealth Group during the first quarter worth about $212,000. Wealthcare Advisory Partners LLC boosted its position in shares of UnitedHealth Group by 6.3% during the first quarter. Wealthcare Advisory Partners LLC now owns 5,512 shares of the healthcare conglomerate’s stock worth $2,727,000 after buying an additional 326 shares during the period. Signet Financial Management LLC raised its holdings in UnitedHealth Group by 8.0% during the first quarter. Signet Financial Management LLC now owns 725 shares of the healthcare conglomerate’s stock worth $358,000 after acquiring an additional 54 shares in the last quarter. Agate Pass Investment Management LLC raised its holdings in UnitedHealth Group by 25.2% during the first quarter. Agate Pass Investment Management LLC now owns 497 shares of the healthcare conglomerate’s stock worth $246,000 after acquiring an additional 100 shares in the last quarter. Finally, Janiczek Wealth Management LLC raised its stake in UnitedHealth Group by 4.7% in the first quarter. Janiczek Wealth Management LLC now owns 1,814 shares of the healthcare conglomerate’s stock valued at $897,000 after buying an additional 82 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.9 %

Shares of UNH opened at $564.48 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The stock has a market capitalization of $521.25 billion, a price-to-earnings ratio of 36.77, a PEG ratio of 1.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a fifty day moving average of $584.16 and a 200-day moving average of $536.49.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the company earned $6.56 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Barclays decreased their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday. Finally, TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.